A number of research firms have changed their ratings and price targets for Werewolf Therapeutics (NASDAQ: HOWL): 6/4/2024 – Werewolf Therapeutics had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $12.00 price target on the stock. 6/3/2024 – Werewolf Therapeutics had its “outperform” rating reaffirmed by analysts at Wedbush. […]
Creative Planning grew its stake in shares of Schwab International Equity ETF (NYSEARCA:SCHF – Free Report) by 5.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 22,058,424 shares of the company’s stock after purchasing an additional 1,130,219 shares during the period. Schwab […]
Peapack Gladstone Financial Corp lowered its holdings in shares of Schwab International Equity ETF (NYSEARCA:SCHF – Free Report) by 0.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 451,397 shares of the company’s stock after selling 537 shares during the period. Peapack Gladstone Financial […]
Rollins Financial Advisors LLC acquired a new stake in Schwab International Equity ETF (NYSEARCA:SCHF – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 9,102 shares of the company’s stock, valued at approximately $336,000. A number of other large investors have also added […]
Partners Capital Investment Group LLP increased its stake in iShares Core S&P 500 ETF (NYSEARCA:IVV – Free Report) by 24.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,438,914 shares of the company’s stock after acquiring an additional 278,793 shares during the […]